Galderma's $978M Bid Falls Short With Q-Med Investors
Skin care company Galderma Pharma SA said Tuesday that it lacked interest among shareholders of Q-Med AB to complete its proposed $978 million takeover of the implant maker....To view the full article, register now.
Already a subscriber? Click here to view full article